Zinc and homocysteine levels in polycystic ovarian syndrome patients with insulin resistance

Biological Trace Element Research

Volumn 158, Issue 3, 2014, Pages 297-304

  Guler, Ismail ^a   Himmetoglu, Ozdemir ^a   Turp, Ahmet ^a   Erdem, Ahmet ^a   Erdem, Mehmet ^a   Onan, M Anil ^a   Taskiran, Cagatay ^a   Taslipinar, Mine Yavuz ^a   Guner, Haldun ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Homocysteine; Hyperinsulinism; Insulin resistance; Metabolic syndrome; PCOS; Zinc

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; TRIACYLGLYCEROL; ZINC;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PROGNOSIS; PROSPECTIVE STUDY; TRIACYLGLYCEROL BLOOD LEVEL; ZINC BLOOD LEVEL; ZINC DEFICIENCY; BLOOD; POLYCYSTIC OVARY SYNDROME; STATISTICAL MODEL; YOUNG ADULT;

ADULT; BODY MASS INDEX; CHOLESTEROL, HDL; FEMALE; HOMOCYSTEINE; HUMANS; INSULIN RESISTANCE; LOGISTIC MODELS; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; TRIGLYCERIDES; YOUNG ADULT; ZINC;

EID: 84901996955     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-014-9941-7     Document Type: Article

References (45)

1. Franks S (1995) Polycystic ovary syndrome. N Engl JMed 333:853-861
2. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19-25
3. Moran L, Norman R (2004) Understanding and managing disturbances in insulin metabolism and body weight in women with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18:719-736 (Pubitemid 40424607)
4. Lord J, Wilkin T (2004) Metformin in polycystic ovary syndrome. Curr Opin Obstet Gynecol 16:481-486 (Pubitemid 41015899)
5. Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A, Licholai T (1992) Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 41:1257-1266
6. Ciaraldi TP, El-Roeiy A, Madar Z, Reichart D, Olefsky JM, Yen SS (1992) Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab 75:577-583
7. Dunaif A (1997) Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18:774-800
8. Dunaif A, Xia J, Book CB, Schenker E, Tang Z (1995) Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest 96:801-810
9. Taylor CG (2005) Zinc, the pancreas, and diabetes: insights from rodent studies and future directions. Biometals 18:305-312
10. Haase H, Maret W (2005) Protein tyrosine phosphatases as targets of the combined insulinomimetic effects of zinc and oxidants. Biometals 18:333-338 (Pubitemid 41298017)
11. Ehrmann DA (2005) Polycystic ovary syndrome. N Engl J Med 352:1223-1236
12. Yarali H, Yildirir A, Aybar F et al (2001) Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome. Fertil Steril 76:511-516
13. Balen A, Rajkowha M (2003) Polycystic ovary syndrome - a systemic disorder? Best Pract Res Clin Obstet Gynaecol 17:263-274 (Pubitemid 36647985)
14. Meyer C, McGrath BP, Teede HJ (2005) Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease. J Clin Endocrinol Metab 90:5711-5716 (Pubitemid 41415480)
15. Kravariti M, Naka KK, Kalantaridou SN et al (2005) Predictors of endothelial dysfunction in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 90:5088-5095 (Pubitemid 41262259)
16. Tzeng C-R, Chang Y-CI, Chang Y-C, Wang C-W, Chen C-H, Hsu M-I (2014) Cluster analysis of cardiovascular and metabolic risk factors in women of reproductive age. Fertil Steril 1-8. doi:10.1016/j.fertnstert.2014.01.023
17. Chausmer AB (1998) Zinc, insulin and diabetes. J Am Coll Nutr 17:109-115
18. Song Y, Wang J, Li X, Cai L (2005) Zinc and the diabetic heart. Biometals 18:325-332 (Pubitemid 41298016)
19. Taneja SK, Kaur R (1990) Pathology of ovary, uterus, vagina and gonadotrophs of female mice fed on Zn-deficient diet. Indian J Exp Biol 28:1058-1065
20. Ebisch IMW, Thomas CMG, Peters WHM, Braat DDM, Steegers-Theunissen RPM (2007) The importance of folate, zinc and antioxidants in the pathogenesis and prevention of subfertility. Hum Reprod Update 13:163-174 (Pubitemid 46323193)
21. Fenkci V, Fenkci S, Yilmazer M, Serteser M (2003) Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease. Fertil Steril 80:123-127
22. Archer JS, Chang RJ (2004) Hirsutism and acne in polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18:737-754 (Pubitemid 40424608)
23. Maret W, Sandstead HH (2006) Zinc requirements and the risks and benefits of zinc supplementation. J Trace Elem Med Biol 20:3-18
24. Balen AH, Laven JSE, Tan S-L, Dewailly D (2003) Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 9:505-514 (Pubitemid 38072143)
25. Legro RS (2007) Clinical evaluation of PCOS. In: Azziz R (ed) The polycystic ovary syndrome: current concepts on pathogenesis and clinical care. Springer, New York, pp 17-27
26. Legro RS, Finegood D, Dunaif A (1998) A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 83:2694-2698 (Pubitemid 28493762)
27. Dutra RL, Cantos GA, Carasek E (2006) Analysis of zinc in biological samples by flame atomic absorption spectrometry: use of addition calibration technique. Biol Trace Elem Res 111:265-279 (Pubitemid 44378652)
28. Guzel NA, Pinar L, Colakoglu F, Karacan S, Ozer C (2012) Long-term callisthenic exercise-related changes in blood lipids, homocysteine, nitric oxide levels and body composition in middle-aged healthy sedentary women. Chin J Physiol 55:202-209
29. DeUgarte CM, Bartolucci AA, Azziz R (2005) Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril 83:1454-1460 (Pubitemid 40615820)
30. Kechrid Z, Hamdi M, Naziroǧlu M, Flores-Arce M (2012) Vitamin D supplementation modulates blood and tissue zinc, liver glutathione and blood biochemical parameters in diabetic rats on a zinc-deficient diet. Biol Trace Elem Res 148:371-377
31. Kurdoglu Z, Kurdoglu M, Demir H, Sahin HG (2012) Serum trace elements and heavy metals in polycystic ovary syndrome. Hum Exp Toxicol 31:452-456
32. Dale PO, Tanbo T, Vaaler S, Abyholm T (1992) Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations. Fertil Steril 58:487-491
33. Ovesen P, Moller J, Ingerslev HJ et al (1993) Normal basal and insulin-stimulated fuel metabolism in lean women with the polycystic ovary syndrome. J Clin Endocrinol Metab 77:1636-1640 (Pubitemid 24000926)
34. Naziroǧlu M (2012) Molecular role of catalase on oxidative stress-induced Ca(2+) signaling and TRP cation channel activation in nervous system. J Recept Signal Transduct Res 32:134-141
35. Naziroǧlu M (2007) New molecular mechanisms on the activation of TRPM2 channels by oxidative stress and ADP-ribose. Neurochem Res 32:1990-2001
36. Fenkci SM, Fenkci V, Oztekin O, Rota S, Karagenc N (2008) Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome. Hum Reprod 23:1602-1606 (Pubitemid 351809704)
37. Kurdoglu Z, Ozkol H, Tuluce Y, Koyuncu I (2012) Oxidative status and its relation with insulin resistance in young nonobese women with polycystic ovary syndrome. J Endocrinol Invest 35:317-321
38. Oteiza PI, Clegg MS, Zago MP, Keen CL (2000) Zinc deficiency induces oxidative stress and AP-1 activation in 3T3 cells. Free Radic Biol Med 28:1091-1099 (Pubitemid 30314707)
39. Beattie JH, Kwun I-S (2004) Is zinc deficiency a risk factor for atherosclerosis? Br J Nutr 91:177-181 (Pubitemid 38268087)
40. Li Y, Zhang H, Jiang C et al (2013) Hyperhomocysteinemia promotes insulin resistance by inducing endoplasmic reticulum stress in adipose tissue. J Biol Chem 288:9583-9592
41. Kiddy DS, Sharp PS, White DM et al (1990) Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clin Endocrinol (Oxf) 32:213-220 (Pubitemid 20039200)
42. Balen AH, Conway GS, Kaltsas G et al (1995) Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 10:2107-2111
43. Ghayour-Mobarhan M, Taylor A, New SA, Lamb DJ, Ferns GAA (2005) Determinants of serum copper, zinc and selenium in healthy subjects. Ann Clin Biochem 42:364-375 (Pubitemid 41354398)
44. Galan P, Viteri FE, Bertrais S et al (2005) Serum concentrations of beta-carotene, vitamins C and E, zinc and selenium are influenced by sex, age, diet, smoking status, alcohol consumption and corpulence in a general French adult population. Eur J Clin Nutr 59:1181-1190 (Pubitemid 41508666)
45. Chimienti F, Aouffen M, Favier A, Seve M (2003) Zinc homeostasis- regulating proteins: new drug targets for triggering cell fate. Curr Drug Targets 4:323-338 (Pubitemid 36443251)